Back to Baker Bros. Advisors LP Baker Bros. Advisors LP

MDGLMDGL

Showing 8 of 30 quarters

Position history for Baker Bros. Advisors LPBaker Bros. Advisors LP's holdings in Madrigal Pharmaceuticals, Inc.

Yes. Baker Bros. Advisors holds 2,143,131 shares of MDGL, worth $1.2B, as of its Q2 2026 13F filing. It increased the position by 1,430 shares (+0.1%) from Q1 2026. Baker Bros. Advisors has held MDGL in every 13F on record since Q1 2019, 30 quarterly filings. MDGL is 5.8% of Baker Bros. Advisors' reported 13F portfolio.

Current Value

$1.2B

Current Shares

2.1M

Total Value Change

+$731.7M

Total Shares Change

+168,541

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2.1M
+0.1%
$1.2B5.8%$536.95
62
2026-Q1
Unchanged
2.1M
0.0%
$1.1B6.4%$523.47
0
2025-Q4
Unchanged
2.1M
0.0%
$1.2B7.3%$582.34
0
2025-Q3
Increased
2.1M
+8.4%
$982.3M7.1%$458.66
67
2025-Q2
Increased
2M
+0.1%
$598M5.8%$302.64
61
2025-Q1
Unchanged
2M
0.0%
$654M7.2%$331.23
0
2024-Q4
Unchanged
2M
0.0%
$609.3M6.5%$308.57
0
2024-Q3
Unchanged
2M
0.0%
$419M4.3%$212.22
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used